{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:54:42Z","timestamp":1784876082294,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1002\/jps.24044","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:09:12Z","timestamp":1402445352000},"page":"2509-2519","source":"Crossref","is-referenced-by-count":35,"title":["Nanoparticle Formulation Improves the Anticonvulsant Effect of Clonazepam on the Pentylenetetrazole-Induced Seizures: Behavior and Electroencephalogram"],"prefix":"10.1016","volume":"103","author":[{"given":"Gerardo","family":"Leyva-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eva","family":"Gonz\u00e1lez-Trujano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"L\u00f3pez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"Couraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babette","family":"Wekslerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Delie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"All\u00e9mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Quintanar-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24044_bb0010","series-title":"Principles of medical pharmacology","first-page":"250","article-title":"Antiseizure drugs","author":"Burnham","year":"1996"},{"key":"10.1002\/jps.24044_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-3806(83)90083-4","article-title":"Increased seizure susceptibility of the immature brain","volume":"283","author":"Mosh\u00e9","year":"1983","journal-title":"Brain Res"},{"key":"10.1002\/jps.24044_bb0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0920-1211(99)00070-4","article-title":"Clinical efficacy of the ketogenic diet","volume":"37","author":"Vining","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1002\/jps.24044_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-197612050-00001","article-title":"Clonazepam: A review of its pharmacological properties and therapeutic efficacy in epilepsy","volume":"12","author":"Pinder","year":"1976","journal-title":"Drugs"},{"key":"10.1002\/jps.24044_bb0030","first-page":"1","article-title":"Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability","volume":"42","author":"Alvarez","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1002\/jps.24044_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2005.06.001","article-title":"Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres","volume":"26","author":"Quintanar-Guerrero","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.24044_bb0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(98)00117-3","article-title":"Solubility and stability of clonazepam in mixed micelles","volume":"169","author":"Hammad","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles","volume":"46","author":"Hammad","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24044_bb0050","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood\u2013brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"key":"10.1002\/jps.24044_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1002\/jps.24044_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.jcbfm.9600525","article-title":"Immortalized human brain endothelial cells and flow-based vascular modeling: A marriage of convenience for rational neurovascular studies","volume":"28","author":"Cucullo","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1002\/jps.24044_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1173196","article-title":"Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium","volume":"325","author":"Coureuil","year":"2009","journal-title":"Science"},{"key":"10.1002\/jps.24044_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24044_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.1041320115","article-title":"Molecular sieving characteristics of the cultured endothelial monolayer","volume":"132","author":"Siflinger-Birnboim","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1002\/jps.24044_bb0080","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1523\/JNEUROSCI.19-16-06733.1999","article-title":"Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice","volume":"19","author":"Ferraro","year":"1999","journal-title":"J Neurosci"},{"key":"10.1002\/jps.24044_bb0085","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1002\/jps.24044_bb0090","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.physbeh.2009.09.005","article-title":"A revised Racine's scale for PTZ-induced seizures in rats","volume":"98","author":"L\u00fcttjohann","year":"2009","journal-title":"Physiol Behav"},{"key":"10.1002\/jps.24044_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/155005949102200305","article-title":"Sleep spindles in epilepsy","volume":"22","author":"Drake","year":"1991","journal-title":"Clin Electroencephalogr"},{"key":"10.1002\/jps.24044_bb0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneur.1976.00500050008002","article-title":"Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures","volume":"33","author":"Mikkelsen","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1002\/jps.24044_bb0105","first-page":"313","article-title":"Further evidence for GABAergic mechanisms in the action of benzodiazepines","volume":"229","author":"Zakusov","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1002\/jps.24044_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00232579","article-title":"The GABA postsynaptic membrane receptor ionophore complex. Site of action of convulsant and anticonvulsant drugs","volume":"39","author":"Olsen","year":"1981","journal-title":"Mol Cell Biochem"},{"key":"10.1002\/jps.24044_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(84)90282-6","article-title":"Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex","volume":"98","author":"Ramanjaneyulu","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.24044_bb0120","first-page":"53","article-title":"Antiepileptic drug development program","volume":"127","author":"Porter","year":"1983","journal-title":"Prog Clin Biol Res"},{"key":"10.1002\/jps.24044_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drug? A proposal based on experimental and clinical consideration","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res"},{"key":"10.1002\/jps.24044_bb0130","series-title":"Antiepileptic drugs: Handbook of experimental pharmacology","first-page":"19","article-title":"Animal models of epilepsy and epileptic seizures","author":"L\u00f6scher","year":"1998"},{"key":"10.1002\/jps.24044_bb0135","series-title":"Epilepsy: A comprehensive textbook","first-page":"1417","article-title":"Screening of new compounds and the role of the pharmaceutical industry","author":"Kupferberg","year":"1997"},{"key":"10.1002\/jps.24044_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02229077","article-title":"The early identification of anticonvulsant activity: Role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models","volume":"16","author":"White","year":"1995","journal-title":"Ital J Neurol Sci"},{"key":"10.1002\/jps.24044_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1476-511X-11-72","article-title":"Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine","volume":"11","author":"Nair","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1002\/jps.24044_bb0150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R","article-title":"Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts","volume":"89","author":"Charman","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24044_bb0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.02.045","article-title":"Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN\u00ae) versus drug nanocrystals","volume":"317","author":"M\u00fcller","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0160","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0196-9781(97)00474-9","article-title":"Efficacy of oral dalargin-loaded nanoparticle delivery across the blood\u2013brain barrier","volume":"19","author":"Schroeder","year":"1998","journal-title":"Peptides"},{"key":"10.1002\/jps.24044_bb0165","doi-asserted-by":"crossref","first-page":"1002S","DOI":"10.1093\/ajcn\/60.6.1002S","article-title":"Effect of triglyceride structure on fat absorption","volume":"60","author":"Bracco","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"10.1002\/jps.24044_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0169-409X(96)00488-7","article-title":"Structure and function of gastro-intestinal lipases","volume":"25","author":"Embleton","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24044_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cis.2010.12.002","article-title":"The role of bile salts in digestion","volume":"165","author":"Maldonado-Valderrama","year":"2011","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1002\/jps.24044_bb0180","series-title":"Proc. 2nd World Meeting APGIAPV","first-page":"573","article-title":"Surface investigation and drug release of drug-loaded solid lipid nanoparticles","author":"Lukowski","year":"1998"},{"key":"10.1002\/jps.24044_bb0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00404-9","article-title":"Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures","volume":"180","author":"Olbrich","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0190","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(02)00035-2","article-title":"Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity","volume":"237","author":"Olbrich","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1020159331420","article-title":"Enzymatic degradation of Dynasan 114 SLN-effect of surfactants and particle size","volume":"4","author":"Olbrich","year":"2002","journal-title":"J Nanoparticle Res"},{"key":"10.1002\/jps.24044_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbiotec.2004.06.007","article-title":"Challenges and solutions for the delivery of biotech drugs\u2014A review of drug nanocrystal technology and lipid nanoparticles","volume":"113","author":"M\u00fcller","year":"2004","journal-title":"J Biotechnol"},{"key":"10.1002\/jps.24044_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0169-409X(96)00489-9","article-title":"Influence of lipolysis on drug absorption from the gastro-intestinal tract","volume":"25","author":"MacGregor","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24044_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejps.2007.02.009","article-title":"Morphological observations on a lipid-based drug delivery system during in vitro digestion","volume":"31","author":"Fatouros","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.24044_bb0215","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.foodres.2010.05.006","article-title":"Delaying lipid digestion through steric surfactant Pluronic F68: A novel in vitro approach","volume":"43","author":"Wulff-P\u00e9rez","year":"2010","journal-title":"Food Res Int"},{"key":"10.1002\/jps.24044_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2005.11.040","article-title":"Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles","volume":"310","author":"Gao","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijpharm.2013.03.046","article-title":"Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain","volume":"448","author":"Kakkar","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.24044_bb0230","series-title":"Methods in enzimology","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/B978-0-12-391860-4.00012-4","article-title":"Lipid nanoparticles for drug targeting to the brain","author":"Bondi","year":"2012"},{"key":"10.1002\/jps.24044_bb0235","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24044_bb0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(95)00023-J","article-title":"Passage of peptides through the blood\u2013brain barrier with colloidal polymer particles (nanoparticles)","volume":"674","author":"Kreuter","year":"1995","journal-title":"Brain Res"},{"key":"10.1002\/jps.24044_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(02)00083-8","article-title":"Enhanced brain targeting by synthesis of 3\u00b4,5\u00b4-dioctanoyl-5-fluoro-2\u00b4-deoxyuridine and incorporation into solid lipid nanoparticles","volume":"54","author":"Wang","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24044_bb0250","first-page":"44","article-title":"Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly (butylcyanoacrylate) nanoparticles","volume":"41","author":"Alyautdin","year":"1995","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.24044_bb0255","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.2042-7158.1996.tb05893.x","article-title":"Blood\u2013brain-barrier transport of lipid microspheres containing clinprost, a prostaglandin I2 analogue","volume":"48","author":"Minagava","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.24044_bb0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-3659(99)00007-3","article-title":"Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain","volume":"59","author":"Yang","year":"1999","journal-title":"J Control Release"},{"key":"10.1002\/jps.24044_bb0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24044_bb0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.colsurfb.2009.11.006","article-title":"Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: Effect of surfactant composition","volume":"76","author":"Kuo","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.24044_bb0275","first-page":"307","article-title":"Evaluation of the anxiolytic effect produced by clonazepam-solid lipid nanoparticles","volume":"33","author":"Leyva-G\u00f3mez","year":"2014","journal-title":"Lat Am J Pharm"},{"key":"10.1002\/jps.24044_bb0280","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1002\/jps.24044_bb0285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","article-title":"RNAi therapeutics: Principles, prospects and challenges","volume":"59","author":"Aagaard","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.24044_bb0290","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","article-title":"Altered lipid metabolism in brain injury and disorders","volume":"49","author":"Adibhatla","year":"2008","journal-title":"Subcell Biochem"},{"key":"10.1002\/jps.24044_bb0295","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2174\/092986711794940860","article-title":"Current trends in the application of nanoparticles in drug delivery","volume":"18","author":"Malam","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1002\/jps.24044_bb0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1079\/BJN20051591","article-title":"The ketogenic diet in children with epilepsy","volume":"95","author":"Papandreou","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1002\/jps.24044_bb0305","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1528-1157.2003.57002.x","article-title":"The ketogenic diet: Adolescents can do it, too","volume":"44","author":"Mady","year":"2003","journal-title":"Epilepsia"},{"key":"10.1002\/jps.24044_bb0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2007.00914.x","article-title":"Clinical aspects of the ketogenic diet","volume":"48","author":"Hartman","year":"2007","journal-title":"Epilepsia"},{"key":"10.1002\/jps.24044_bb0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","article-title":"Anticonvulsant mechanisms of the ketogenic diet","volume":"48","author":"Bough","year":"2007","journal-title":"Epilepsia"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915304627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915304627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T12:05:37Z","timestamp":1565525137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915304627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0022354915304627"],"URL":"https:\/\/doi.org\/10.1002\/jps.24044","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}